You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PFS

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Burkitt's Lymphoma, Burkitt'S-like Lymphoma Trial in Houston (Rituximab, Cyclophosphamide, Doxorubicin)

Completed
Has Results
  • Burkitt's Lymphoma
  • Burkitt'S-like Lymphoma
  • Houston, Texas
    The University of Texas M. D. Anderson Cancer Center
Apr 18, 2018

Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ofatumumab, ibrutinib)

Completed
Has Results
  • Relapsed or Refractory Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +75 more
Dec 3, 2019

Hematologic Malignancy, Refractory Lymphoma Trial in Boston (Radiotherapy)

Not yet recruiting
  • Hematologic Malignancy
  • Refractory Lymphoma
  • Radiotherapy
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 19, 2021

Lung Squamous Cell Carcinoma Stage IV, Nonsquamous Nonsmall Cell Tumor of Lung, Metastatic Uveal Melanoma Trial in Houston

Terminated
  • Lung Squamous Cell Carcinoma Stage IV
  • +2 more
  • ADV/HSV-tk
  • +3 more
  • Houston, Texas
    Houston Methodist Hospital
Nov 17, 2020

Chronic Myeloid Leukemia Trial in Germany, Netherlands (TKI discontinuation, nilotinib)

Active, not recruiting
  • Chronic Myeloid Leukemia
  • Freiburg, Baden-Württemberg, Germany
  • +14 more
Nov 4, 2021

Maintenance Niraparib in Treatment of Ovarian CanceR

Recruiting
  • Ovarian Cancer
  • +2 more
  • Niraparib
  • Bath, United Kingdom
  • +14 more
Jan 5, 2022

Head Neck Cancer Trial in Cleveland, Dallas, Milwaukee (cetuximab, cisplatin, intensity-modulated radiation therapy)

Completed
Has Results
  • Head and Neck Cancer
  • Cleveland, Ohio
  • +3 more
Aug 19, 2020

Germ Cell Tumor, Teratoma, Choriocarcinoma Trial in Worldwide (paclitaxel, ifosfamide, cisplatin)

Recruiting
  • Germ Cell Tumor
  • +10 more
  • Birmingham, Alabama
  • +122 more
Mar 22, 2022

MGMT-Unmethylated Glioblastoma Trial in Hangzhou (Anlotinib)

Recruiting
  • MGMT-Unmethylated Glioblastoma
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Jan 24, 2021

Radiation-Induced Dermatitis Trial in Chengdu (Tetrahydrobiopterin)

Not yet recruiting
  • Radiation-Induced Dermatitis
  • Chengdu, Sichuan, China
    est China Second Hospital of Sichuan University
Feb 25, 2022

Advanced Solid Tumor, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (MT-6402)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Los Angeles, California
  • +7 more
Feb 25, 2022

Gastrointestinal Tumors, Adenocarcinoma Trial in Worldwide (IMU-131, Cisplatin and either Fluorouracil (5-FU) or Capecitabine or

Active, not recruiting
  • Gastrointestinal Neoplasms
  • Adenocarcinoma
  • IMU-131
  • Cisplatin and either Fluorouracil (5-FU) or Capecitabine or Oxaliplatin and capecitabine.
  • Tbilisi, Georgia
  • +21 more
Jan 19, 2022

Pancreatic Cancer Trial in Villejuif (LV5FU2, Streptozocin, Capecitabine)

Recruiting
  • Pancreatic Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jan 6, 2020

Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB

Recruiting
  • Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • +2 more
  • Intensity-Modulated Radiation Therapy
  • +4 more
  • Birmingham, Alabama
  • +21 more
May 13, 2022

Advanced or Metastatic Esophageal Squamous Cell Carcinoma Trial in Worldwide (RO7121661, RO7247669, Nivolumab)

Recruiting
  • Advanced or Metastatic Esophageal Squamous Cell Carcinoma
  • Buenos Aires, Argentina
  • +79 more
Aug 3, 2022

Breast Cancer Trial in Beijing (apatinib+oral etoposide)

Completed
  • Breast Cancer
  • apatinib+oral etoposide
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Dec 1, 2020

Gastric Carcinoma Stage IV, Esophagogastric Junction Adenocarcinoma Stage IV Trial in Moscow (Irinotecan, Oxaliplatin, 5-FU)

Recruiting
  • Gastric Carcinoma Stage IV
  • Esophagogastric Junction Adenocarcinoma Stage IV
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 11, 2021

Multiple Myeloma Trial in Austria, Germany (Carfilzomib, Thalidomide, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Graz, Austria
  • +20 more
Jan 18, 2022

Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,

Recruiting
  • Non-Small Cell Lung Carcinoma (NSCLC)
  • +2 more
  • Selinexor 100 mg
  • +6 more
  • Ashdod, Israel
  • +10 more
Jan 30, 2023

Hodgkin Disease Trial in Worldwide (Brentuximab vedotin, Doxorubicin, Vinblastine)

Completed
Has Results
  • Hodgkin Disease
  • Brentuximab vedotin
  • +3 more
  • Aurora, Colorado
  • +13 more
Jun 17, 2022

Refractory Metastatic Colorectal Cancer Trial in Worldwide (Trifluridine/Tipiracil, Bevacizumab)

Active, not recruiting
  • Refractory Metastatic Colorectal Cancer
  • Phoenix, Arizona
  • +102 more
Apr 4, 2022

Chronic Lymphocyte Leukemia, Adult Patients Trial in Italy (Ibrutinib, Rituximab)

Active, not recruiting
  • Chronic Lymphocyte Leukemia
  • Adult Patients
  • Alessandria, Italy
  • +35 more
Oct 5, 2020

Stage II Melanoma Trial in Wollstonecraft (Relatlimab and nivolumab fixed dose combination (FDC))

Not yet recruiting
  • Stage II Melanoma
  • Relatlimab and nivolumab fixed dose combination (FDC)
  • Wollstonecraft, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

Metastatic NSCLC Trial in Worldwide (Ramucirumab, Placebo, Erlotinib)

Active, not recruiting
Has Results
  • Metastatic Non-Small Cell Lung Cancer
  • Los Angeles, California
  • +109 more
Apr 18, 2022

Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors Trial in Worldwide (Everolimus, Placebo, Best

Completed
Has Results
  • Advanced NET of GI Origin
  • +2 more
  • La Jolla, California
  • +96 more
Jul 13, 2021